🔬 Divi’s Labs Wins Big! 🌍💊 Signs a long-term deal with a global pharma giant for the supply of advanced intermediates! 🧪 What’s in the deal? ✔️ High-value custom synthesis agreement ✔️ Revenue-boosting potential 💸 ✔️ Strengthens Divi’s leadership in custom manufacturing 🏭 Capacity Expansion Incoming: 💰 ₹650–750 Cr investment ➡️ Fully funded via customer’s phase-wise advance 🚧 New facilities = new opportunities! 🤐 Customer name & financial terms remain confidential — but the impact? Definitely not silent. 🔥 📈 Divi’s is doubling down on innovation, scale, and global partnerships — custom synthesis is the future, and Divi’s is leading the charge! 🧬🚀 #DivisLabs #PharmaDeal #CustomSynthesis #MakeInIndia #GlobalPharma #DivisUpdate #StockMarketIndia #PharmaStocks ✅ follow @plus_trades 🚀join our free Telegram channel for daily stock updates, breakout ideas, and the latest crypto news! t.me/plusstocks